| Literature DB >> 31305145 |
Le Ba Vinh1,2, Se Jin Jo3, Phong Nguyen Viet2, Dan Gao1, Kyoung Won Cho4, Eun-Jeong Koh4, Sung Sun Park4, Young Ran Kim3, Young Ho Kim1, Seo Young Yang1.
Abstract
Stauntonia hexaphylla (Lardizabalaceae) is an important medicinal plant in Korea, Japan, and China. Its leaves are used to treat many diseases because of their analgesic, sedative, and diuretic effects; however, there are few reports on their chemical constituents and biological activities. This study divided an ethanol extract into dichloromethane (DCM), ethyl acetate (EtOAc), and water fractions. Bioassay-guided fractionation of the ethanol extracts led to the isolation of seven compounds (1-7). To our knowledge, this is the first report of 1-7 from S. hexaphylla. The anti-inflammatory effects were investigated by suppressing cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) in Western blots. The ethanol extract (20 µg/mL), DCM fraction (20 µg/mL), and compound 1 (10 µM) decreased COX-2 and iNOS expression significantly in LPS-induced RAW264.7 cells. These results suggest that S. hexaphylla leaves and compound 1 are useful candidates for treating inflammatory and other diseases.Entities:
Keywords: COX-2; Lardizabalaceae; Stauntonia hexaphylla; anti-inflammatory effects; iNOS
Year: 2019 PMID: 31305145 DOI: 10.1080/14786419.2019.1638385
Source DB: PubMed Journal: Nat Prod Res ISSN: 1478-6419 Impact factor: 2.861